RXST•benzinga•
RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges
Summary
RxSight shares down premarket on revised FY25 outlook. CEO cites headwinds in premium IOL market and economy.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 3, 2025 by benzinga